Structural Image
Diagnostic TestPatients will undergo structural and functional (rsfMRI) brain MRIs (total time= ~15 minutes) at enrollment (prior to HD-Chemo/ASCT) and approximately 3-4 months after ASCT.
Other names: Brain MRI
NCT Number: NCT03508765
The purpose of this study is to learn about possible changes in thinking (cognitive) abilities, such as memory skills, and in brain anatomy and function, in adults with multiple myeloma who are treated with high-dose chemotherapy followed by ASCT.
Looking for future studies?
Notify Me60 year–75 year
All sexes
Interventional
Not applicable
Rutgers University - Data Analysis, New Brunswick, New Jersey, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients will undergo structural and functional (rsfMRI) brain MRIs (total time= ~15 minutes) at enrollment (prior to HD-Chemo/ASCT) and approximately 3-4 months after ASCT.
Other names: Brain MRI
Patients will undergo structural and functional (rsfMRI) brain MRIs (total time= ~15 minutes) at enrollment (prior to HD-Chemo/ASCT) and approximately 3-4 months after ASCT.
Other names: rsfMRI
Evaluates auditory attention and working memory
Other names: WAIS-IV
Assesses selective auditory attention
Other names: BTA
Assesses visual scanning, graphomotor speed, and setshifting
Assesses attention and susceptibility to interference
A timed test of verbal fluency.
Other names: COWAT
The HVLT-R is a test of verbal learning and recall.
Other names: HVLT-R
assesses perceived depression
Other names: CES-D
A 13-item questionnaire designed to assess symptoms and concerns specific to the QOL of patients with fatigue
Other names: FACIT-FS
Blood samples will be collected at each time point (pre-ASCT; 3-4 months and post-ASCT) to assess serum levels of inflammatory cytokines.
Time frame: up to 4 months following chemotherapy and ASCT
Time frame: up to 4 months following chemotherapy and ASCT
Memorial Sloan Kettering Cancer Center
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04975555
Acute Lymphoblastic Leukemia, Blood Protein Disorders
Birmingham, Alabama, United States
View Trial DetailsNCT05024045
B-cell Lymphoma, Blood Protein Disorders
Tucson, Arizona, United States
View Trial DetailsNCT01139476
Blood Protein Disorders, Cardiovascular Diseases
Iowa City, Iowa, United States
View Trial DetailsNCT06483139
Acute Kidney Injury, Blood Protein Disorders
Boston, Massachusetts, United States
View Trial Details